Research Sites Invited to Participate in ASCO-ACCC Pilot Project
ASCO is excited to announce the launch of a new project stemming from a collaboration between ASCO and the Association of Community Cancer Centers (ACCC) to address the lack of racial and ethnic diversity in cancer treatment trials. The goal of the collaboration is to develop practical strategies and solutions to increase clinical trial participation among people with cancer from racial and ethnic communities historically underrepresented in cancer treatment trials.
This initial project will test a research site self-assessment tool and an implicit bias training program, which are designed to address one of the greatest barriers to people participating in clinical trials: trials not routinely being offered to people who are eligible. This initial phase is a pilot project focused on screening and participation outcomes for patients who are Black and/or Hispanic/Latinx. In subsequent efforts, ASCO and ACCC plan to modify the resources to address other underrepresented racial and ethnic groups.
Individual research sites located in the U.S. are invited to apply to participate in the pilot project to test these resources. We are seeking over 40 oncology research sites and locations from a mix of research and practice settings, including small and large research sites, and community and academic-based oncology programs from diverse geographic regions. Learn more about this initiative.
Recruitment will close on June 11, 2021.
We hope you consider this opportunity and encourage you to share this information with your colleagues.